| Increased demand for NAD+ relative to ATP drives aerobic glycolysis A Luengo, Z Li, DY Gui, LB Sullivan, M Zagorulya, BT Do, R Ferreira, ... Molecular cell 81 (4), 691-707. e6, 2021 | 285 | 2021 |
| Direct and indirect regulators of epithelial–mesenchymal transition–mediated immunosuppression in breast carcinomas A Dongre, M Rashidian, EN Eaton, F Reinhardt, P Thiru, M Zagorulya, ... Cancer discovery 11 (5), 1286-1305, 2021 | 85 | 2021 |
| Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer BL Horton, DM Morgan, N Momin, M Zagorulya, E Torres-Mejia, ... Science Immunology 6 (64), eabi8800, 2021 | 78 | 2021 |
| Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer M Zagorulya, L Yim, DM Morgan, A Edwards, E Torres-Mejia, N Momin, ... Immunity 56 (2), 386-405. e10, 2023 | 32 | 2023 |
| A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A M Simon, J Yang, J Gigas, EJ Earley, E Hillpot, L Zhang, M Zagorulya, ... The EMBO Journal 41 (21), e110393, 2022 | 22 | 2022 |
| Impact of anatomic site on antigen-presenting cells in cancer M Zagorulya, E Duong, S Spranger Journal for Immunotherapy of Cancer 8 (2), 2020 | 16 | 2020 |
| Sensitivity of primary fibroblasts in culture to atmospheric oxygen does not correlate with species lifespan A Patrick, M Seluanov, C Hwang, J Tam, T Khan, A Morgenstern, ... Aging 8 (5), 841-847, 2016 | 14 | 2016 |
| Once upon a prime: DCs shape cancer immunity M Zagorulya, S Spranger Trends in Cancer 9 (2), 172-184, 2023 | 11 | 2023 |
| Direct and Indirect Regulators of Epithelial-Mesenchymal Transition (EMT)-mediated Immunosuppression in Breast Carcinomas [Internet]. Cancer Discov. 2020 A Dongre, M Rashidian, EN Eaton, F Reinhardt, P Thiru, M Zagorulya, ... CD-20-0603.[PubMed][CrossRef][Google Scholar], 0 | 9 | |
| A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A M Simon, J Yang, J Gigas, EJ Earley, E Hillpot, L Zhang, M Zagorulya, ... The EMBO Journal 42 (3), e113326, 2023 | 3 | 2023 |
| 1087 Addition of IL-2 overcomes lung tumor resistance to IL-12 by coordinating cytotoxic and regulatory T cell responses B Horton, M Zagorulya, N Momin, Y Agarwal, K Wittrup, S Spranger Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 2 | 2022 |
| Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2 BL Horton, AD D’Souza, M Zagorulya, CV McCreery, GC Abhiraman, ... JCI insight 8 (19), 2023 | 1 | 2023 |
| 232 The epithelial-to-mesenchymal transition (EMT) contributes to immunosuppression in breast carcinomas and regulates their response to immune checkpoint blockade A Dongre, R Weinberg, M Rashidian, E Eaton, F Reinhardt, P Thiru, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| Sleep fights infection M Zagorulya J of Young Investigators, 2015 | 1 | 2015 |
| Differentiation and Expansion of Tumor-Infiltrating T Cell Clonotypes Occurs in the Spleen Following Immune Checkpoint Blockade DM Morgan, BL Horton, M Zagorulya, JC Love, S Spranger bioRxiv, 2023.09. 04.555982, 2023 | | 2023 |
| Dendritic cell dysfunction restrains cytotoxic T cell responses against cancer M Zagorulya Massachusetts Institute of Technology, 2023 | | 2023 |
| 1052 Tissue-specific interferon-gamma drives regulatory T-cells to restrain DC1-mediated priming of cytotoxic T-cells against lung cancer M Zagorulya, L Yim, D Morgan, A Edwards, E Torres-Mejia, N Momin, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 664 Pulmonary priming of tumor-reactive CD8+ T cells by DC1 is impaired by regulatory T cells M Zagorulya, D Morgan, L Yim, B Horton, E Torres-Mejia, S Spranger Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A692-A692, 2021 | | 2021 |
| 303 Non-functional T cell responses in non-small cell lung cancer are induced during tumor antigen-specific T cell priming in the mediastinal lymph node B Horton, D Morgan, E Torres-Mejia, M Zagorulya, V Bhandarkar, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Potentiating the efficacy of immune checkpoint blockade by targeting the epithelial-to-mesenchymal transition (EMT) in breast carcinomas. A Dongre, M Rashidian, EN Eaton, F Reinhardt, P Thiru, M Zagorulya, ... CANCER IMMUNOLOGY RESEARCH 9 (2), 2021 | | 2021 |
